← Leaderboards
Christina Mayer
Advanced Bioscience Laboratories, Inc.
$9,347,093
Attributed
$9,347,093
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.6M · FY2023–25$10M$7.5M$5M$2.5M$0
'23
'24
'25
Funding mix
By agency
NIH$9,347,093 · 2
By mechanism
N01$9,347,093 · 2
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- James Richardson$33,534,082
- Timothy Fouts$52,990,932
- Peter Silvera$18,392,128
- Thomas Vancott$47,641,448
- Fred Mack$9,334,595
Others in their field
Other Rising Stars on “United States National Institutes Of Health”
- Gary Mays · Axle Informatics, Llc$64,794,917
- Mari Ostendorf · University Of Washington$51,931,230
- Nancy Jean Sullivan · Boston University Medical Campus$42,041,758
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Joan Grand · Mitre Corporation$32,826,287
Research focus
United States National Institutes Of HealthBacterial Drug ResistanceClinical PainCyclic GmpDiagnosticServicesSpeedGram-Negative BacteriaHelping To End Addiction Long-TermInfectious AgentManufactureNational Institute Of Allergy And Infectious DiseasePainPain ManagementPre-ClinicalProduct DevelopmentDocumentationArea
Grant awards (4)
CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN$3,730,598
N01 · FY2025 · DA · contact PI
CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN$5,609,495
N01 · FY2024 · DA · contact PI
Task Area B: NIAID Preclinical Services for AMR Diagnostics Development$3,500
N01 · FY2023 · AI · contact PI
TASK A: NIAID Preclinical Services for AMR Diagnostics Development - Product Development Processes and Documentation$3,500
N01 · FY2023 · AI · contact PI